Testosterone reduces the bioactivity of luteinizing hormone (LH) in man.
AffiliationDepartment of Endocrinology, Christie Hospital, Manchester, UK.
MetadataShow full item record
AbstractThe effect of testosterone on LH bioactivity was investigated in six adult men (aged 40-56 years) with primary hypogonadism. Two men received a 400 mg testosterone implant, another two 800 mg, and the final two patients received both doses in consecutive courses separated by at least 4 weeks. Plasma samples, obtained before and at 1, 2, 4, 8, 16 and 24 weeks after treatment, were analysed for bioactive LH by the mouse Leydig cell bioassay, and immunoreactive LH and testosterone (T) by standard radioimmunoassays. The bioactive to immunoreactive (B:I) LH ratio, an index of LH biopotency, was calculated and the results compared with those from a group (n = 17) of healthy adult men. Before treatment, both bioactive and immunoreactive LH levels in the patients were higher and T levels lower than in the normal men (P less than 0.001). The mean +/- SD B:I LH ratio (3.5 +/- 0.6) in the patients was greater (P less than 0.05) than in the controls (2.7 +/- 0.7), indicating that in primary testicular failure, increased amounts of LH with enhanced bioactivity are secreted. Following T administration, a dose-related increase in circulating T and a reciprocal decrease in LH levels was observed between 1 and 16 weeks of treatment. However, there was a more pronounced decline in bioactive rather than immunoreactive LH levels, so that the B:I LH ratios decreased (P less than 0.001) from basal values after treatment. There was a negative correlation (r = -0.82, P less than 0.001) between circulating T levels and B:I LH ratios; the stronger the feedback signal, the lower the B:I LH ratio. It is concluded that testosterone negative feedback modifies not only the quantity but also the biological quality of secreted LH.
CitationTestosterone reduces the bioactivity of luteinizing hormone (LH) in man. 1990, 32 (1):73-82 Clin Endocrinol
- Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in man.
- Authors: Tsatsoulis A, Shalet SM, Robertson WR
- Issue date: 1988 Aug
- Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive.
- Authors: Mitchell R, Hollis S, Rothwell C, Robertson WR
- Issue date: 1995 May
- The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
- Authors: Tenover JS, Matsumoto AM, Plymate SR, Bremner WJ
- Issue date: 1987 Dec
- Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
- Authors: Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schaison G
- Issue date: 2000 Sep
- Changes in the bioactivity to immunoreactivity ratio of circulating luteinizing hormone in impotent men treated with testosterone undecanoate.
- Authors: Carani C, Celani MF, Zini D, Baldini A, Della Casa L, Marrama P
- Issue date: 1989 Mar